Details for 2013715426

Up to date per 04.04.2026

Actions

Title / Product Name

HETEROBIZYKLISCHE VERBINDUNGEN ALS BETA-LACTAMASE-INHIBITOREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013715426

EP Publication Number

2834239

E-Number

958177

Language

PCT Number

GB13050869

Publication Date

11.02.2015 A

27.12.2017 B1

Registration Date

27.12.2017

AT Publication Date

15.01.2018

Application Date

02.04.2013

Registration Number

Priorities

02.04.2012

201261618993 P

IPC

C07D 471/08 20060101AFI20131022BHEP

Maximum Duration of Protection

02.04.2033

Owner

Entasis Therapeutics Limited2 Kingdom Street London W2 6BDGB

Representative

Barger W. Dipl.Ing., Israiloff P. Dipl.Ing. Dr. techn.Operngasse 41010 WienAT

Inventor

MCGUIRE, HelenAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

BIST, ShantaAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

BIFULCO, NeilAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

ZHAO, LiangAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

WU, YeAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

HUYNH, HoanAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

XIONG, HuiAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

COMITA-PREVOIR, JanelleAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

DUSSAULT, DaemianAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

GENG, BolinAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

CHEN, BrendanAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

DURAND-REVILLE, ThomasAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

GULER, SatenigAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451US

Information about Fees